新抗原驱动的B细胞和CD4毛囊T细胞的协作促进了抗瘤CD8T细胞的反应
Can Cui1, Jiawei Wang2, Eric Fagerberg1
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Cell
|December 1, 2021
概括
CD4 T毛囊辅助细胞和B细胞的相互作用促进肺腺癌的抗瘤免疫力. 瘤新抗原驱动TFH细胞的发展,增强CD8T细胞的功能,以改善生存.
科学领域:
- 免疫学
- 癌症学
- 癌症研究
背景情况:
- CD4 T毛囊辅助细胞 (TFH) 支持B细胞的生殖中心 (GC) 形成.
- TFH-B细胞相互作用在癌症免疫中的作用在很大程度上仍未确定.
- 肺腺癌 (LUAD) 是全球癌症相关死亡的主要原因.
研究的目的:
- 研究TFH-B细胞相互作用在肺腺癌 (LUAD) 免疫中的作用.
- 探索TFH-B细胞特征对患者生存的影响.
- 阐明TFH-B细胞介导的抗瘤反应的机制.
主要方法:
- 在LUAD患者队列中分析TFH和GCB细胞的转录特征.
- 开发一种表达瘤新抗原的小鼠LUAD模型.
- 在体内评估TFH- B细胞相互作用,IL-21的产生和CD8T细胞的功能.
主要成果:
- 在LUAD患者中,TFH和GCB细胞特征的丰富与改善的存活率相关.
- 瘤特异性TFH和GCB细胞相互作用以及IL-21对瘤控制至关重要.
- TFH细胞的发育取决于B细胞和瘤新抗原.
- TFH-B细胞相互作用增强了抗瘤CD8T细胞的作用.
结论:
- 在LUAD中,TFH-B细胞相互作用是抗瘤免疫的关键组成部分.
- 瘤新抗原作为TFH细胞命运和功能的关键调节者.
- 针对TFH-B细胞轴和IL-21可能为LUAD提供新的治疗策略.
相关概念视频
Tumor Immunotherapy
725
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
725
T Cell Activation and Clonal Selection
8.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
8.5K
Cytotoxic T Cells-mediated Immune Response
4.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
4.3K
T Cell Types and Functions
1.5K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.5K
B Cell Activation and Differentiation
9.5K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
9.5K
Cell-mediated Immune Responses
75.3K
Overview
75.3K


